A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection
Abstract Continuously emerging SARS-CoV-2 Omicron subvariants pose a threat thwarting the effectiveness of approved COVID-19 vaccines. Especially, the protection breadth and degree of these vaccines against antigenically distant Omicron subvariants is unclear. Here, we report the immunogenicity and...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-025-01062-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!